ABBVIE INC. vs. Rallybio Corporation Common Stock
ABBVIE INC. and Rallybio Corporation Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABBV | RLYB | |
|---|---|---|
| Market Cap | $430.82 billion | $85.65 million |
| Revenue (TTM) | — | $858,000 |
| Net Income (TTM) | — | $-7,817,000 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | RLYB | |
|---|---|---|
| Price / Book | — | 1.70 |
| Price / Sales | — | 99.83 |
ABBV and RLYB split the valuation factors evenly.
Profitability
| ABBV | RLYB | |
|---|---|---|
| Net Margin | — | -911.07% |
| Return on Equity | — | -15.55% |
ABBV and RLYB split the profitability factors evenly.
Dividend
| ABBV | RLYB | |
|---|---|---|
| Dividend Yield | 2.81% | — |
ABBV and RLYB split the dividend factors evenly.
Risk & Sentiment
| ABBV | RLYB | |
|---|---|---|
| Short Interest | 0.85% | 0.02% |
RLYB leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, RLYB overview, RLYB financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.